Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

268 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Long term efficacy and safety of rivaroxaban plus cilostazol in the treatment of critical ischemia of the lower limbs in a frail, elderly patient with non valvular atrial fibrillation.
Trani A, Benedetto P, Di Leo F, Baiano A, Esposito A, Menna D, Allegretti A, Cappiello PA, Dell'Edera D. Trani A, et al. Among authors: benedetto p. J Pharm Health Care Sci. 2020 Aug 3;6:17. doi: 10.1186/s40780-020-00173-9. eCollection 2020. J Pharm Health Care Sci. 2020. PMID: 32774874 Free PMC article.
Study on Psychological Stress Perceived among Employees in an Italian University during Mandatory and Voluntary Remote Working during and after the COVID-19 Pandemic.
Tobia L, Vittorini P, Di Battista G, D'Onofrio S, Mastrangeli G, Di Benedetto P, Fabiani L. Tobia L, et al. Among authors: di benedetto p. Int J Environ Res Public Health. 2024 Mar 26;21(4):403. doi: 10.3390/ijerph21040403. Int J Environ Res Public Health. 2024. PMID: 38673316 Free PMC article.
Groin Pain Syndrome Italian Consensus Conference update 2023.
Bisciotti GN, Zini R, Aluigi M, Aprato A, Auci A, Bellinzona E, Benelli P, Bigoni M, Bisciotti A, Bisciotti A, Bona S, Brustia M, Bruzzone M, Canata GL, Carulli C, Cassaghi G, Coli M, Corsini A, Costantini A, Dallari D, Danelli G, Danesi G, Della Rocca F, DE Nardo P, DI Benedetto P, DI Marzo F, DI Pietto F, Eirale C, Ferretti A, Fogli M, Foglia A, Guardoli A, Guglielmi A, Lama D, Maffulli N, Manunta AF, Massari L, Mazzoni G, Moretti B, Moretti L, Nanni G, Niccolai R, Occhialini M, Panascì M, Parra MF, Pigalarga G, Randelli F, Sacchini M, Salini V, Santori N, Tenconi P, Tognini G, Vegnuti M, Zanini A, Volpi P. Bisciotti GN, et al. Among authors: di benedetto p. J Sports Med Phys Fitness. 2024 Apr;64(4):402-414. doi: 10.23736/S0022-4707.23.15517-4. Epub 2023 Dec 21. J Sports Med Phys Fitness. 2024. PMID: 38126972
Erdafitinib versus pembrolizumab in pretreated patients with advanced or metastatic urothelial cancer with select FGFR alterations: cohort 2 of the randomized phase III THOR trial.
Siefker-Radtke AO, Matsubara N, Park SH, Huddart RA, Burgess EF, Özgüroğlu M, Valderrama BP, Laguerre B, Basso U, Triantos S, Akapame S, Kean Y, Deprince K, Mukhopadhyay S, Loriot Y; THOR cohort 2 investigators. Siefker-Radtke AO, et al. Ann Oncol. 2024 Jan;35(1):107-117. doi: 10.1016/j.annonc.2023.10.003. Epub 2023 Oct 21. Ann Oncol. 2024. PMID: 37871702 Clinical Trial.
268 results